ホーム › 膠腫 › コロンビア特別区 › Washington
Washington、DCにおける膠腫の臨床試験
Washingtonとその周辺地域（約30マイル以内）の拠点で、膠腫に関する19件の研究が参加者を募集しています。研究を開いて、参加資格と連絡方法を確認してください。
公式研究テキスト（英語）
ここで研究参加者を募集していますか？ このページの上部に表示できます — 30日間 $99 →
A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)
被験者募集中第1/2相
- Children's National Medical Center, Washington D.C.
Novel Indenoisoquinolone CMYC/TOPOISOMERASE 1 Inhibitor (LMP744) in Recurrent Glioblastoma
被験者募集中第1/2相
- National Institutes of Health Clinical Center, Bethesda · 7マイル先
Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII
被験者募集中第2相
- Johns Hopkins Sibley Memorial Hospital, Washington D.C.
ACT001 for the Treatment of Diffuse Intrinsic Pontine Gliomas and H3K27-altered High Grade Gliomas
被験者募集中第2相
- Children's National Medical Center, Washington D.C.
NgFUS NIVO: NeuroNavigation-Guided Focused Ultrasound With Nivolumab in Relapsed and Progressive DMG and Other High Grade Brain Tumors
被験者募集中第1相
- Children's National Hospital, Washington D.C.
Targeted Pediatric High-Grade Glioma Therapy
被験者募集中観察研究
- Children's National Medical Center, Washington D.C.
Study of Olutasidenib and Temozolomide in HGG
被験者募集中第2相
- Children's National Medical Center, Washington D.C.
A Phase I/II Study of Zotiraciclib for Recurrent Malignant Gliomas With Isocitrate Dehydrogenase 1 or 2 (IDH1 or IDH2) Mutations
被験者募集中第1/2相
- National Institutes of Health Clinical Center, Bethesda · 7マイル先
PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma
被験者募集中第2相
- Children's National Medical Center, Washington D.C.
Trametinib and Everolimus for Treatment of Pediatric and Young Adult Patients With Recurrent Gliomas (PNOC021)
被験者募集中第1相
- Children's National Medical Center, Washington D.C.
Hypofractionation Trial of Re-irradiation in Good Prognosis Recurrent Glioblastoma
被験者募集中第1相
- National Institutes of Health Clinical Center, Bethesda · 7マイル先
PLX038 in Primary Central Nervous System Tumors Containing MYC or MYCN Amplifications
被験者募集中第1/2相
- National Institutes of Health Clinical Center, Bethesda · 7マイル先
MAPK Inhibition Combined With Anti-PD1 Therapy for BRAF-altered Pediatric Gliomas
被験者募集中第1/2相
- Children's National Hospital, Washington D.C.
Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion
被験者募集中早期第1相健康なボランティア歓迎
- Children's National Medical Center, Washington D.C.
A Study of RNA-lipid Particle (RNA-LP) Vaccines for Newly Diagnosed Pediatric High-Grade Gliomas (pHGG) and Adult Glioblastoma (GBM)
被験者募集中第1相
- Children's National Hospital, Washington D.C.
Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant
被験者募集中第2相
- Children's National Medical Center, Washington D.C.
Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
被験者募集中第1/2相
- Sibley Memorial Hospital, Washington D.C.
A Pilot Study of Larotrectinib for Newly-Diagnosed High-Grade Glioma With NTRK Fusion
被験者募集中早期第1相
- Children's National Medical Center, Washington D.C.
Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms
被験者募集中第1相
- National Institutes of Health, Bethesda · 7マイル先
他の都市における膠腫の試験
- New York City, NY25件の研究
- Houston, TX23件の研究
- Boston, MA20件の研究
- Philadelphia, PA16件の研究
- Columbus, OH15件の研究
- Miami, FL15件の研究
- San Francisco, CA14件の研究
- Chicago, IL13件の研究
- Durham, NC12件の研究
- Seattle, WA11件の研究
- St. Louis, MO10件の研究
- Aurora, CO10件の研究
Washingtonにおける他の研究
- がん（全種類）58件の研究
- 非小細胞肺癌55件の研究
- 乳がん46件の研究
- 転移性癌43件の研究
- 肺がん41件の研究
- 前立腺がん38件の研究
- 肥満症33件の研究
- 大腸癌29件の研究
- 心血管疾患28件の研究
- 膀胱癌26件の研究
- 急性骨髄性白血病24件の研究
- 卵巣がん23件の研究
ClinicalTrials.govより、2026/10/06時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。